Regeneration of skeletal muscles is required throughout life to ensure optimal performance. Therefore, a better understanding of the resident cells involved in muscle repair is essential. Muscle repair relies on satellite cells (SCs), the resident myogenic progenitors, but also involves the contribution of interstitial cells including fibro/adipocyte progenitors (FAPs). To elucidate the role of the fibroblast growth factor (FGF) signaling in these two cell populations, we previously analyzed freshly isolated cells for their FGF receptor (FGFR) signature. Transcript analysis of the four Fgfr genes revealed distinct expression profiles for SCs and FAPs, raising the possibility that these two cell types have different FGF-mediated processes. Here, we pursued this hypothesis exploring the role of the Klotho genes, whose products are known to function as FGFR co-receptors for the endocrine FGF subfamily. Isolated SC and FAP populations were analyzed in culture, exhibiting spontaneous myogenic or adipogenic differentiation, respectively. aKlotho expression was not detected in either population. bKlotho expression, while not detected in SCs, was strongly upregulated in FAPs entering adipogenic differentiation, coinciding with expression of a panel of adipogenic genes and preceding the appearance of intracellular lipid droplets. Overexpression of bKlotho in mouse cell line models enhanced adipogenesis in NIH3T3 fibroblasts but had no effect on C2C12 myogenic cells. Our study supports a pro-adipogenic role for bKlotho in skeletal muscle fibro/adipogenesis and calls for further research on involvement of the FGF-FGFR-bKlotho axis in the fibro/adipogenic infiltration associated with functional deterioration of skeletal muscle in aging and muscular dystrophy.
Introduction
Skeletal muscle regeneration requires the participation of myogenic progenitors, termed satellite cells (SCs) , that reside underneath the myofiber basal lamina and contribute progeny for myofiber repair [1, 2] . Effective muscle repair, however, not only relies on SCs, but also involves the contribution of interstitial fibroblastic cells [3, 4] . A subset of these skeletal muscle interstitial cells, defined by the expression of the cell surface antigen Sca1, has been characterized as fibro/adipocyte progenitors (FAPs) based on a propensity to generate both fibroblasts and adipocytes [5] [6] [7] [8] [9] . These muscleresident FAPs have been shown to be activated during muscle injury, normally acting in synergy with SCs to promote efficient muscle regeneration [5, 10] . Nevertheless, skeletal muscle regeneration is impaired with age and pathological conditions such as muscular dystrophy. In these situations, healthy contractile tissue was shown to be progressively infiltrated, or even replaced, by fibrotic and adipose tissue that contributes to deterioration of muscle function [11] [12] [13] [14] . Although FAPs have been proposed to be the source of this intramuscular fibro/adipogenesis, the regulation of this pathogenic progression is just beginning to be unveiled [15, 16] .
The fibroblast growth factor (FGF) family, of which the first member was identified in 1974 as a promoter of fibroblast proliferation [17] , comprises over 20 FGFs that are key players in the processes of proliferation and differentiation of a wide range of cells and tissues [18] [19] [20] . The FGFs are classified by their mechanism of action as paracrine (FGFs 1-10, 16-18, 20, 22) , endocrine (FGFs 15 /19, 21, 23) and intracrine (FGFs 11-14) [21, 22] . With the exception of intracrine FGFs that act as intracellular molecules, FGFs exert their effects through FGF tyrosine kinase receptors (FGFRs) that are encoded by four different genes (Fgfr1, Fgfr2, Fgfr3, Fgfr4) [20, 23] . Most studies on the role of FGF signaling in skeletal muscle have focused on the prototypic (i.e. paracrine) FGF subfamily. Selective paracrine FGFs have been detected at the transcript and even the protein levels in adult skeletal muscle and have been known for a long time to act as mitogens of satellite cells (i.e. FGF1, FGF2, FGF4, FGF6) [24] [25] [26] [27] [28] [29] . These paracrine FGFs require heparan sulfate as a cofactor for their stable interaction with FGFRs [20, 30, 31] . Differently, the endocrine FGFs have a low binding affinity for heparan sulfate and their interaction with FGFRs typically requires the transmembrane FGFR co-receptors encoded by the Klotho genes [aKlotho (also known as Klotho) and bKlotho] [23, 32, 33] . Our long-term interest in the role of the FGF family in adult myogenesis [25, [34] [35] [36] [37] [38] has prompted our recent study on the expression pattern of the FGF receptor (FGFR) genes (Fgfr1, Fgfr2, Fgfr3, Fgfr4) in SCs and in FAPs. Analyzing freshly isolated populations, we showed that while Fgfr1 was expressed at a relatively high level and Fgfr3 was detected at relatively low level by both SCs and FAPs, the expression of the other two Fgfr genes varied between the two cell types: Fgfr2 was below detection level in SCs, while some Fgfr2 expression was demonstrated by the FAPs, and Fgfr4 was expressed only by SCs [39] . The latter expression analysis of the four 'traditional' Fgfr genes coding for the FGFRs is furthered in the current study that focuses on the expression profile and overexpression outcomes of the Klotho genes. The primary site of aKlotho expression is the kidney while bKlotho is primarily expressed in the liver and adipose tissue [40] [41] [42] [43] . We and other laboratories have previously reported on the detection of low levels of aKlotho and bKlotho in skeletal muscle [40, [42] [43] [44] [45] . We further observed a marked up-regulation in bKlotho gene expression in the diaphragm muscle of dystrophin-null (mdx 4cv ) mice, concomitant with the mdx muscle pathology of enhanced fibrosis and adipogenicity [43] , raising the possibility that bKlotho is involved in muscle fibrosis.
In the current study we have analyzed the endogenous expression profile of the Klotho genes in FAP and SC cultures. aKlotho expression was not detected in either population. bKlotho was strongly upregulated in FAPs concomitant with adipogenic differentiation, while SC cultures never expressed bKlotho, nor underwent adipogenesis, even when cultured in adipogenic induction medium. Forced expression of bKlotho in mouse cell line models enhanced adipogenesis in NIH3T3 fibroblasts but had no effect on C2C12 myogenic cells. These results provide novel insight into the potential role of bKlotho as a pro-adipogenic factor in skeletal muscle fibro/adipogenesis.
Results
bKlotho expression is associated with fibro/ adipogenesis while myogenic cells neither enter adipogenesis nor express bKlotho Expression of the Klotho genes was surveyed in cultures derived from satellite cells (SCs) and fibro/adipogenic progenitors (FAPs) freshly isolated from hindlimb skeletal muscle. SCs and FAPs were isolated by fluorescence-activated cell sorting (FACS) based on their respective antigen signatures of CD31
, respectively, and cultured in our standard primary culture, mitogen-rich medium that contains 20% fetal bovine serum (FBS), 10% horse serum (HS) and 1% chicken embryo extract. This growth medium, which has been widely used by us to promote the proliferation and spontaneous myogenic differentiation of SC cultures, also supports the proliferation and spontaneous adipogenic differentiation of FAP cultures [7, 46] (Fig. 1) . The plated cells were followed morphologically and processed for RT-PCR analyses at several time points (Fig. 1) . The FAPs gave rise to fibroblastic cells that underwent spontaneous adipogenic differentiation in culture, as detected by the emergence of cells containing multivacuolar lipid dro-plets (Fig. 1A ) associated with adipocyte maturation [47] [48] [49] [50] . As anticipated, SCs gave rise to myogenic cultures that differentiated over time into multinucleated myotubes (Fig. 1B) . Our initial RT-PCR studies showed that aKlotho was not expressed in any of the populations at any time point analyzed while bKlotho expression was observed only in the FAP cultures, with expression rising at later time points. Quantitative RT-PCR analyses clearly demonstrated a robust rise of bKlotho expression in the FAP cultures by culture day 14 (Fig. 1C) . This increase in bKlotho expression coincided with the upregulation of the adipogenic marker Ap2 (Fig. 1D ) and preceded the morphological adipogenic differentiation as adipocytes were only seen at low frequency (~10%) in culture day 14, but were present at high frequency by culture day 21 (Fig. 1A) . Differently, in the SC cultures, bKlotho expression was not detected (Fig. 1C) and Ap2 was only detected at a low basal level, at all time points analyzed (Fig. 1D) . Typically, cultures of SCs isolated by FACS as described above are purely myogenic, but adipocytelike cells have been sporadically detected in some of such preparations. Nevertheless, even when using adipogenic induction conditions, which promote robust adipogenic differentiation in FAP cultures ( Fig. 2A,B) , the occurrence of adipocytes remains extremely infrequent in the SC cultures (Fig. 2C-C″,  arrows) . Significantly, using a permanent reporter marking of the myogenic lineage (i.e. MyoD-Cre driven green fluorescent protein (GFP) expression; further details in Fig. 2 legend) , we have clearly demonstrated that adipocytes developing in SC cultures are not progeny of SCs, but reflect rare non-myogenic cells co-isolated with the sorted SC population (Fig. 2C-C″ ). This conclusion is in agreement with an earlier report relying on isolated single myofibers [51] .
SC and FAP cultures were further characterized by semi-quantitative RT-PCR for the expression of a number of characteristic myogenic markers (Pax7, myogenin) and adipogenic markers (adipsin, Pparc2) (Fig. 3) . In view of bKlotho involvement in FGFR signaling (detailed in 'Introduction'), we additionally evaluated expression of the four Fgfr genes to establish if there are changes in Fgfr expression associated with bKlotho upregulation during fibro/adipogenesis. In a previous study, we only analyzed Fgfr expression in day 7 cultures of such FACS-sorted populations [39] , a time point preceding bKlotho upregulation and the emergence of adipocytes in FAP cultures (as shown in Fig. 1 ). As shown in Fig. 3 , Fgfr1 and Fgfr3 were expressed in both cell types at a relatively higher and lower level, respectively, and their levels did not change appreciably across the three time points for each cell population. Differently, Fgfr4 expression was specific to the myogenic cells, in agreement with our previous studies [25, 39] . Strikingly, Fgfr2 was strongly upregulated in the FAP cultures by day 14, paralleling the strong upregulation in bKlotho and the adipogenic genes adipsin and Pparc2 by day 14. SC cultures only showed relatively minimal Fgfr2 expression (with some increase by culture day 21) and no expression of bKlotho, adipsin and Pparc2 at any time point (Fig. 3) .
Establishing bKlotho-overexpressing C2C12 myoblasts and NIH3T3 fibroblasts Next, we were interested in determining whether forced expression of bKlotho could induce adipogenic differentiation in myogenic cells or accelerate adipogenesis in fibroblastic cells. To facilitate overexpression experiments we switched to the well-characterized myogenic C2C12 and fibroblastic NIH3T3 mouse cell line models. These cell lines were maintained either in standard 10% FBS growth medium or switched to adipogenic induction conditions. Based on our initial morphological observations, while C2C12 retained a strict myogenic fate in both media, NIH3T3 underwent some adipogenic differentiation only when switched to adipogenic induction conditions. Before embarking on overexpression experiments, we determined baseline endogenous expression levels for aKlotho, bKlotho and Ap2 genes in these C2C12 and NIH3T3 cell lines maintained either in standard 10% FBS growth medium or switched to the adipogenic induction conditions (Fig. 4) . In agreement with the aforementioned primary culture studies, aKlotho expression was not detected in either the myogenic or fibroblastic cell lines, and C2C12 cells did not exhibit bKlotho expression or up-regulation of Ap2 expression regardless of the culture medium (Fig. 4A,C) . NIH3T3 fibroblasts demonstrated no bKlotho expression in the standard 10% FBS medium but robustly upregulated bKlotho expression when cultured under adipogenic conditions (Fig. 4B,D) . The adipogenic marker Ap2, expressed at a low basal level in NIH3T3 cells cultured in 10% FBS medium, was also markedly up-regulated after cells were switched to adipogenic induction conditions, just preceding bKlotho upregulation (Fig. 4B,D) as observed for FAP cultures (Fig. 1 ). We also have been interested in the status of Fgfr gene expression in these two cell lines. We previously published the Fgfr expression profile for the C2C12 cells [37] , demonstrating that levels of Fgfr1 and Fgfr3 expression did not change appreciably throughout the days in culture,
Lineage tracing analysis of FAP and SC cultures maintained under adipogenic induction conditions. FAPs and SCs were isolated from hindlimb muscles of adult MyoD Cre 9 R26 mTmG mice by FACS and cultured in our standard (mitogen-rich) primary culture medium until reaching near confluence, then switched to adipogenic induction conditions for up to 2 weeks. The R26 mTmG reporter operates on a membrane-localized dual fluorescence system where all cells express Tomato until Cre-mediated excision of the Tomato gene allows for GFP expression in the targeted cell lineage [72] . Consequently, due to ancestral MyoD expression in the myogenic lineage [71] , in the MyoD Cre 9 R26 mTmG cross, all skeletal muscles and their resident SCs are GFP + while all other cells are Tomato + , as described in our previous studies [7, 39, 73] . Fgfr2 expression was barely detectable, while peak Fgfr4 expression coincided with the onset of myogenic differentiation. Here, we have analyzed Fgfr expression profile in NIH3T3 cells (Fig. 5 ). Fgfr1 and Fgfr2 were relatively strongly expressed with a slight increase in their levels after adipogenic induction ( Fig. 5A ), while Fgfr3 and Fgfr4 were expressed at lower levels ( Fig. 5B) . Overall, the gene expression results obtained with the 'wildtype' NIH3T3 fibroblasts and the C2C12 myogenic cell line corroborate our observations made with the FAPs and SCs primary cultures, suggesting a role for bKlotho during adipogenic differentiation in fibroblasts while the myogenic cells neither enter differentiation nor upregulate bKlotho. C2C12 and NIH3T3 stable cell lines overexpressing bKlotho were developed using the PiggyBac transposon vector system as described in 'Materials and methods'. In order to monitor bKlotho-expressing cells, we opted to overexpress a bKlotho-GFP fusion construct that also allows insights into bKlotho localization in live cells. To ensure that the fusion of bKlotho with GFP does not alter the effect of overexpressed bKlotho, we also overexpressed a control bKlotho-IRES-GFP bicistronic construct, which enables independent expression of the bKlotho and GFP proteins. As additional controls for the specificity of the effect of overexpressed bKlotho, we generated aKlotho-IRES-GFP and GFP expressing cell lines. Representative GFP fluorescence images (live cultures) of all C2C12 and NIH3T3 cell lines developed are shown in Fig. 6A . Overexpression of GFP, alone, or when using a/bKlotho-IRES-GFP constructs, resulted in a typical ubiquitous GFP fluorescence pattern throughout the cell. Differently, C2C12 and NIH3T3 cells overexpresssing the bKlotho-GFP fusion construct demonstrated specifically localized GFP fluorescence in perinuclear and cell-cell contact regions as further depicted in higher magnification images in Fig. 7 . Production of the bKlotho-GFP fusion protein was also verified by western blot using a GFP antibody (data not shown). bKlotho transcripts were measured for all developed cell lines maintained in standard 10% FBS growth medium, and as expected (see Fig. 4A ,B, 10% FBS condition) were detected only in the bKlotho-GFP and bKlotho-IRES-GFP expressing cell lines (Fig. 6B,C) . For both C2C12 and NIH3T3 cells, the level of overexpressed bKlotho was over 2000-fold higher when compared with the highest level of endogenous bKlotho expressed in wildtype NIH3T3 cells exposed to adipogenic conditions (i.e. compare Figs 6B,C and 4B).
As mentioned earlier, the use of the bKlotho-GFP fusion construct has permitted insight into bKlotho localization in live cells. In both C2C12 and NIH3T3 cells, bKlotho-GFP was detected in discrete perinuclear regions (Fig. 7A-D 0 ), presumably within the endoplasmic reticulum and Golgi network [52] , while also occasionally observed at cell-cell contacts (Fig. 7B,B 0 and D,D 0 , arrowheads). This pattern of bKlotho distribution determined by direct GFP localization is in accordance with a previous cytological study that has detected bKlotho predominantly in the endoplasmic reticulum with only a small portion of the protein found in the plasma membrane [53] . The latter study has further shown that bKlotho harbors an endoplasmic reticulum retrieval signal, and was hypothesized to play a role in regulating FGFR glycosylation within the endoplasmic reticulum [53] .
Overexpression of bKlotho does not influence C2C12 myoblasts but enhances adipogenic differentiation in NIH3T3 fibroblasts C2C12 cells overexpressing bKlotho-GFP retained myogenicity and clearly did not enter adipogenic differentiation regardless of medium conditions. Whether maintained in standard 10% FBS medium or switched to adipogenic induction conditions, the three C2C12 cell lines (wildtype, GFP and bKlotho-GFP) demonstrated extensive proliferation with some myotube formation, without appearance of any morpho- Fig. 3 . Semi-quantitative RT-PCR analyses of FAP and SC cultures harvested on days 7, 14, and 21 following initial plating. FAP and SC populations were isolated by flow cytometry from hindlimb muscles of adult wildtype mice and cultured in our standard (mitogen-rich) primary culture medium (as in Fig. 1 ). Pax7, myogenin, bKlotho, adipsin, Pparc2, Ffgr1, Fgfr2, Fgfr3, and Fgfr4 transcript levels were determined and the expression level of Tbp was used as a reference gene.
logical evidence for adipocyte development (data not shown). Furthermore, when cells were switched to the differentiation synchronizing 2% HS medium, overexpression of bKlotho-GFP in C2C12 cells did not influence myogenic differentiation at the morphological level (i.e. myotube development, Figs 6A and 8A) or according to the expression level of the myogenic-specific transcription factor myogenin (Fig. 8B) .
Different from C2C12 myoblasts, NIH3T3 fibroblasts do undergo some adipogenic differentiation but only when switched from 10% FBS medium to adipogenic induction conditions (Fig. 9A) . Overexpression of bKlotho did not induce adipogenic differentiation when NIH3T3 cells were maintained in standard 10% FBS medium, but resulted in increased adipogenic differentiation for NIH3T3 cells switched to adipogenic induction conditions. As readily apparent in images of Oil-Red-O staining and further demonstrated in subsequent quantification (Fig. 9) , overexpression of bKlotho (bKlotho-GFP or bKlotho-IRES-GFP constructs) resulted in 52-79% increase in lipid levels compared with control NIH3T3 cell lines (wildtype, and overexpressing GFP or aKlotho-IRES-GFP) (P < 0.001, Fig. 9B,C) .
Following the above demonstration of a bKlotho effect on morphological adipogenic differentiation in NIH3T3 cells, we further explored the effect of bKlotho overexpression on transcript levels of the early adipogenic regulatory genes Ap2 and Pparc2. These genes have been typically described as early adipogenic genes [54, 55] and as shown above for FAPs cultures, their expression precedes the accumulation of lipid droplets during adipogenic differentiation (Figs 1 and  3) . Here, the bKlotho-GFP NIH3T3 cells were com- pared with the wildtype and GFP control lines for Ap2 and Pparc2 transcript levels (Fig. 10 ). Cells were first cultured in standard 10% FBS medium and then switched to adipogenic induction conditions; day 0 in Fig. 8 refers to cultures just prior to the switch and subsequent days 2, 4 and 8 reflect time following the switch to the adipogenic conditions. Both Ap2 and Pparc2 were upregulated in all the three NIH3T3 cell lines over the time spent in the adipogenic induction conditions, but for each gene there was no apparent difference in expression profile between the three cell lines analyzed (Fig. 10) . Notably, similar to the lag in the onset of Pparc2 expression compared with Ap2 expression observed with FAP cultures undergoing spontaneous adipogenic differentiation (Figs 1 and 3) , in the NIH3T3 lines, expression of Ap2 was already present at day 0, while expression of Pparc2 was first detected only after adipogenic induction (Fig. 10 ). bKlotho overexpression also had no apparent effect on transcript levels of the four Fgfr genes (data not shown) with their expression profiles during the course of adipogenic differentiation resembling the pattern shown in Fig. 5 for wildtype NIH3T3.
Discussion
This study of bKlotho expression profiling and overexpression outcome introduces bKlotho as a novel player in skeletal muscle fibro/adipogenesis, while myogenic cells neither express bKlotho nor are affected by bKlotho overexpression. First, our results reveal that bKlotho expression is specifically upregulated in the FAP cultures derived from skeletal muscle, concomitant with the upregulation of the adipogenic markers Ap2, Pparc2 and adipsin, and preceding the phenotypic emergence of adipocytes. Second, our overexpression experiments have suggested that bKlotho is important during fibro/adipogenesis as bKlotho-overexpressing NIH3T3 fibroblastic cells exhibited a marked increase in adipogenic differentiation when exposed to adipogenic conditions. Differently, myogenic cultures derived from SCs or from the C2C12 cells never entered adipogenesis (even when maintained in adipogenic induction conditions), nor expressed bKlotho, and overexpression of bKlotho in the C2C12 cell line clearly did not induce adipogenic differentiation. In the NIH3T3 cells overexpressing bKlotho, while an enhanced adipogenesis at the morphological level was observed, we found that bKlotho overexpression had no apparent impact at transcript levels of the early adipogenic regulatory genes Ap2 and Pparc2. This observation, taken together with our finding that NIH3T3 cells overexpressing bKlotho (like control cells) did not enter adipogenesis unless switched from standard 10% FBS medium to adipogenic induction conditions, may indicate that bKlotho promotes later stages of adipogenic differentiation and that an intrinsic pro-adipogenic program needs to be activated before bKlotho can induce its effect. We further When switched to adipogenic induction conditions, bKlotho-GFP overexpressing cells demonstrated a significant increase in lipid levels compared with wildtype (67% higher, P < 0.001) and GFP overexpressing (59% higher, P = 0.001) controls. Similarly, in another complementary study, NIH3T3 cells overexpressing bKlotho-IRES-GFP exhibited a significant increase in the level of Oil-Red-O staining compared with wildtype (52% higher, P < 0.0001) and aKlotho-IRES-GFP overexpressing cells (79% higher, P < 0.0001). Data shown in (B) and (C) are from two independent studies. Results are noted as mean AE SEM. Data were analyzed with a one-way ANOVA followed by a Bonferroni post hoc test, n = 14 and n = 6 for data in (B) and (C), respectively.
propose that such pro-adipogenic intrinsic program is not active in myogenic cells, as these do not enter adipogenesis even in adipogenic induction conditions regardless of bKlotho overexpression. While the determination of which FGF and which FGFR are involved in the FGF-FGFR-bKlotho axis during skeletal muscle fibro/adipogenesis awaits future studies, it is attractive to propose FGFR2 for the receptor based on its strong transcriptional upregulation observed concomitant with bKlotho upregulation in the cultured FAPs, and to suggest FGF21, a member of the endocrine FGF subfamily, as the candidate ligand, in view of its established presence in skeletal muscle and its role within adipose tissue. FGF21 is a key mediator of systemic glucose and lipid metabolism, playing a role in obesity and diabetes [44, [56] [57] [58] . While FGF21 was first identified as predominantly expressed in the liver [59] , it has been later shown to be secreted by a number of tissues including skeletal muscle [60] [61] [62] . In particular, a recent wave of studies has revealed FGF21 as a stressinduced endocrine factor that targets adipose tissue through the FGFR-bKlotho complex [63] [64] [65] [66] [67] [68] [69] with bKlotho expression determining the tissue specificity of FGF21 action [70] .
Collectively, future studies on the dynamics of skeletal muscle fibro/adipogenesis and the involvement of the FGF-FGFR-bKlotho axis are likely to provide important insight into the molecular and cellular changes in skeletal muscles associated not only with aging and muscular dystrophy where fibrosis and fat infiltration have been demonstrated, but also with diabetes and obesity where cellular modifications have not been fully characterized yet.
Materials and methods

Animals
Mice were from our colonies maintained under 12: 12 h light-dark cycle and fed ad libitum Lab Diet 5053 (Purina Mills, St Paul, MN, USA). Animal care and experimental procedures were approved by the Institutional Animal Care and Use Committee at the University of Washington. Experimental mice were typically 3-to 6-month-old males. Mouse strains included wildtype C57BL/6 and double heterozygote MyoD Cre Isolation of satellite cells and fibro/adipogenic progenitors by fluorescence-activated cell sorting
Cells were isolated from pooled hindlimb muscles (tibialis anterior, gastrocnemius and extensor digitorum longus) of adult mice following our previously published procedure [7, 39, 73] . SC and FAP populations were then purified by FACS. All sorted cells were collected within the G0-G1 [7, 39, 73] . In brief, for both mouse strains, cell suspensions were released from harvested muscles by collagenase/dispase digestion and were first incubated with 10 lM Hoechst 33342 (Sigma-Aldrich, St Louis, MO, USA) for 30 min at 37°C to label cell nuclei, followed by incubation with a combination of fluorescently conjugated monoclonal antibodies (all from eBioscience, San Diego, CA, USA) that included Sca1-APC (clone D7), CD31-PECy7 (clone 390), CD45-PECy7 (clone 30-F11) and CD34-FITC (clone RAM34) with the latter being used only when sorting cells from wildtype but not from MyoD Cre 9 R26 mTmG mice.
Antibodies were diluted at a ratio of 300 ng of antibody per 10 6 cells for Sca1-APC, 1 lg of antibody per 10 6 cells for CD34-FITC, and 600 ng of antibody per 10 6 cells for CD31-PECy7 and CD45-PECy7. Cell sorting was performed using an Influx Cell Sorter (BD Biosciences, San Jose, CA, USA) equipped with 350, 488, and 638 nm lasers. Gates were determined by comparing fluorophore signal intensities between the unstained control and each single antibody/fluorophore control, and sorted cells were collected in our mitogen-rich growth medium and then cultured for morphological followup and RNA isolation as described below.
Satellite cell and fibro/adipogenic progenitor cultures
The basal solution for all culture medium preparations used in this study consisted [46] ). Cultures were initiated at a density of (3-4) 9 10 4 cells per well and incubated at 37°C, 5% CO 2 , using our standard DMEM-based mitogen-rich growth medium containing 20% fetal bovine serum (FBS) and 10% horse serum (HS) (both from Gibco), and 1% chicken embryo extract [46] . After the initial plating, growth medium was replaced every 3 days. When indicated, cultures were switched to adipogenic induction conditions as described in the next section.
Cultures of C2C12 and NIH3T3 cell lines, and adipogenic induction conditions
Murine C2C12 myoblasts [74, 75] and NIH3T3 fibroblasts [76] were cultured in 24-well plates at a cell density of 12 000 and 30 000 cells per well, respectively. Both cell lines were incubated at 37°C, 5% CO 2 , using a DMEMbased growth medium containing 10% FBS. When indicated, cells were switched to adipogenic induction conditions (adapted from [77] ). Briefly, near-confluent cultures were switched into DMEM-based medium containing 10% FBS, 0.5 mM isobutylmethylxanthine, 1 lgÁmL À1 dexamethasone, and 5 lgÁmL À1 insulin (SigmaAldrich) for 2 days followed by a switch to a high-insulin medium consisting of DMEM with 10% FBS and 5 lgÁmL À1 insulin for the remainder of the culture time.
The high insulin medium was typically changed every other day or daily when reaching high density. For control cultures, a medium change to fresh standard growth medium was applied at the time the parallel cultures were switched to adipogenic induction conditions and at any subsequent medium change.
Oil-Red-O staining and quantification
Oil-Red-O staining of triglycerides and lipids was performed on cultured cells as previously described [50] . For each condition, a minimum of nine wells from three independent experiments were quantified. Briefly, cultures fixed in 2% paraformaldehyde were incubated with OilRed-O working solution for 30 min, and then washed with Tris-buffered saline. Oil-Red-O staining level was quantified by extracting the dye in each well using 100 lL of 100% isopropanol for 1 min (protocol adapted from [78] ). The absorbance of Oil-Red-O dye in each well was then quantified on a NanoDrop spectrophotometer (Agilent Technologies, Palo Alto, CA, USA) at 510 nm wavelengths.
Gene expression analyses
To isolate total RNA, cultured cells were rinsed twice with DMEM before adding the lysis buffer from the RNeasy Plus Micro kit (Qiagen, Valencia, CA, USA) and processed according to the manufacturer's instructions. The RNA was then quantified using an Agilent Bioanalyzer or a NanoDrop spectrophotometer and reverse transcribed (at 0.4 ngÁlL À1 and 20 ngÁlL À1 for quantitative and semiquantitative gene expression analysis, respectively) into cDNA using the iScript reverse transcriptase (Bio-Rad Laboratories, Hercules, CA, USA) as previously described [79] . Quantitative RT-PCR analyses were performed as previously described [45] . Gene expression was determined by SYBR Green-based quantitative PCR using 1 lL cDNA per reaction (20 The final concentration of all primers was 500 nM except for the bKlotho reverse primer, which was used at 300 nM final concentration. Raw qPCR cycle threshold values for each individual sample were normalized to Eef2 (eukaryotic translation elongation factor 2) reference gene expression [39, 45] . Notably, Eef2 expression level showed little variation between primary culture treatment groups (average C t 14.88 AE 0.13) or cell lines treatment groups (average C t 16.30 AE 0.04). Each sample was analyzed in triplicate. Genes were considered expressed if cycle threshold values (raw C t ) of < 33 cycles were detected.
Semi-quantitative RT-PCR analyses were performed following our previously published protocol [79] . Briefly, for all PCR reactions, we used 5 lL of cDNA per PCR reaction (25 lL final volume) and the following cycling parameters: 95°C for 15 min, 24-34 cycles of 94°C for 40 s, 60°C for 50 s, 72°C for 1 min, with a final extension step of 72°C for 10 min. The PCR forward and reverse primer sequences for Pax7, myogenin, bKlotho, adipsin, Fgfr1, Fgfr2, Fgfr3, Fgfr4 and Tbp were as in our previous publications [37, 43, 79] . The PCR forward and reverse primer sequences for Pparc2 were GCTGTTATGGGTGAAACTCTG and ATAAGGTG-GAGATGCAGGTTC (351 bp). All primers were used at a final concentration of 400 nM. Expression of Tbp (TATA box binding protein) housekeeping control gene served as a quality and loading control as in [43] ). PCR products were separated on 1.5% agarose gels containing 1 : 10 000 dilution of SYBR Green I (Molecular Probes, Thermo Fisher Scientific). Gels were imaged using Gel Logic 212 Pro (Carestream Health, Rochester, NY, USA).
Statistics
Data were analyzed with a one-way ANOVA. When ANOVA revealed significant differences between groups, post hoc t tests were performed with a Bonferroni correction to the level of significance. Data are presented as mean AE SD or mean AE SEM as indicated in figure legends, where n is the number of experimental replicates; P values <0.01 were considered significant.
Generation of overexpressing stable cell lines
Mammalian expression constructs employing the PiggyBac transposon system were used to produce NIH3T3 and C2C12 transgenic stable cell lines for experimentation. Such stable overexpressing cell lines were created after initial attempts to transiently overexpress aKlotho-EGFP or bKlotho-EGFP fusion constructs (driven by the CMV or EF1a promoter, using the pCR3.1 expression vector) resulted in high levels of cell death. Transiently transfected cells exhibited strong endoplasmic reticulum localized GFP expression and died 2-3 days after transfection potentially due to the endoplasmic reticulum overload response [82] . The latter plasmids (deposited as pCMV-Kl-EGFP and pCMV-Klb-EGFP at Addgene, Cambridge, MA, USA, plasmids no. 45532 and no. 45531, respectively) were further used as subcloning constructs to develop the PiggyBac expression constructs as described below.
Full-length coding sequences (CDS) for aKlotho and bKlotho were cloned from murine kidney or adipose tissue cDNA, respectively; these tissues show high expression of each of the respective Klotho genes [40, 42] (and see supplemental material in [43] ). Both genes were PCR amplified using pfu ultraII HotStart fusion polymerase (Agilent) under the following conditions: 95°C 1 min, followed by 40 cycles of 95°C for 20 s, 61°C for 20 s, and 72°C for 1 min 45 s, with a final extension at 72°C for 3 min. The following primer sets were used for gene amplification (forward and reverse, respectively): aKlotho, GCATGC-TAGCCCGCGC and CGTTCACATTACTTATAACTTC TCTGGC; and bKlotho, GATCCAGGCTAATCATTGA-CAGGG and GTAAGTTACCAGTACATGGAGCCG.
The bKlotho-GFP fusion construct was created by cloning the bKlotho CDS (lacking a stop codon and with PCR added 5 0 HindIII and 3 0 SpeI restriction sites) into a modified pCR3.1 vector driving emerald GFP (emGFP, termed GFP throughout the article) expression. The bKlotho-GFP sequence was then subcloned into a modified PiggyBac transposon vector (System Biosciences, Mountain View, CA, USA) containing the human eukaryotic elongation factor-1a (hEEF1A) promoter, a T2A self-cleaving peptide sequence and the puromycin resistance gene (at 5 0 HindIII and 3 0 MluI restriction sites between the hEEF1A promoter and the T2A sequence; pPB-hEEF1A-Klb-GFP-T2A-Puro R ).
To enable T2A and puromycin translation, the bKlotho-GFP sequence was modified to remove the GFP stop codon (by PCR) prior to cloning. A GFP control vector was also created by amplifying the GFP CDS (with 5 0 HindIII and 3
0
MluI restriction sites) and cloning into the PiggyBac backbone vector (pPB-hEEF1A-GFP-T2A-Puro R ). To independently express bKlotho and GFP, a bicistronic bKlotho-IRES-GFP vector was also created. This was achieved by PCR amplifying the bKlotho CDS (with stop codon) from pCMV-KLb-EGFP with added 5 0 NheI and 3 0 NotI restriction sites into a vector containing an IRES-GFP sequence (GFP lacking stop codon). The entire bKlotho-IRES-GFP fragment was then subcloned into the PiggyBac vector backbone (using NheI and MluI restriction sites present between the hEEF1A promoter and the T2A sequence; pPB-hEEF1A-Klb-IRES-GFP-T2A-Puro R ). A similar aKlotho-IRES-GFP bicistronic construct was also produced by cloning the aKlotho CDS (derived from pCMVKl-EGFP) into the pPB-hEEF1A-Klb-IRES-GFP-T2A-Puro R vector in place of the bKlotho transgene (pPBhEEF1A-Kl-IRES-GFP-T2A-Puro R ). All constructs were thoroughly sequenced for accuracy prior to experimentation (Genewiz, Seattle, WA, USA). Stable bKlotho-GFP and GFP expressing cells were created for both NIH3T3 and C2C12 cells whereas only NIH3T3 cells were used to produce stable bKlotho-IRES-GFP and aKlotho-IRES-GFP overexpressing cell lines. One hundred thousand cells per transfection were electroporated using the Neon electroporation system (Thermo Fisher Scientific), according to the manufacturer's protocols (C2C12; one pulse at 1400 V for 30 ms, NIH3T3; two pulses at 1400 V for 20 ms). A total of 700 ng of total plasmid DNA was added for each transfection at a 2.5 : 1 ratio of transposon to transposase (System Biosciences). Transfected cells were plated into two separate 10 cm plates and cultured for 3 days prior to the addition of puromycin for selection (3 lgÁmL
À1
). Once stable cell lines were established, frozen stocks were created and working cultures were grown in the absence of puromycin to match wildtype cell culture conditions.
